nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adagrasib for KRAS G12C mutated advanced non-small-cell lung cancer
|
Smit, Egbert F |
|
|
406 |
10503 |
p. 576-577 |
artikel |
2 |
Adagrasib versus docetaxel in KRAS G12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
|
Barlesi, Fabrice |
|
|
406 |
10503 |
p. 615-626 |
artikel |
3 |
Assessing monoclonal antibodies for respiratory virus infections
|
White, Nicholas J |
|
|
406 |
10503 |
p. 595-596 |
artikel |
4 |
Childhood epilepsy
|
Menon, Ramshekhar N |
|
|
406 |
10503 |
p. 636-649 |
artikel |
5 |
Costs prohibiting access to cystic fibrosis drug
|
Cousins, Sophie |
|
|
406 |
10503 |
p. 587-588 |
artikel |
6 |
Disturbed sleep
|
Womersley, Kate |
|
|
406 |
10503 |
p. 590-591 |
artikel |
7 |
Efficacy and safety of monoclonal antibody PEP for rabies
|
GeurtsvanKessel, Corine H |
|
|
406 |
10503 |
p. 578-579 |
artikel |
8 |
Extending aromatase inhibitor treatment in early breast cancer; longer is better for many
|
Howell, Sacha J |
|
|
406 |
10503 |
p. 573-575 |
artikel |
9 |
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy
|
|
|
|
406 |
10503 |
p. 603-614 |
artikel |
10 |
From the hibakusha: 80 years of peace and scientific discovery
|
Kamiya, Kenji |
|
|
406 |
10503 |
p. 597 |
artikel |
11 |
From zero to impact: political leadership key to advancing the non-communicable disease response
|
Dain, Katie |
|
|
406 |
10503 |
p. 580-582 |
artikel |
12 |
Holding nations accountable: strategic litigation for health
|
The Lancet, |
|
|
406 |
10503 |
p. 571 |
artikel |
13 |
James Harrison
|
Burki, Talha |
|
|
406 |
10503 |
p. 594 |
artikel |
14 |
Legal accountability for climate change
|
Samarasekera, Udani |
|
|
406 |
10503 |
p. 585-586 |
artikel |
15 |
Metrics for diplomats: is mortality from non-communicable diseases increasing or decreasing?
|
Bovet, Pascal |
|
|
406 |
10503 |
p. 582-584 |
artikel |
16 |
Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trial
|
Kulkarni, Prasad S |
|
|
406 |
10503 |
p. 627-635 |
artikel |
17 |
Respiratory syncytial virus vaccine effectiveness
|
Wagner, Jeffrey |
|
|
406 |
10503 |
p. 599 |
artikel |
18 |
Respiratory syncytial virus vaccine effectiveness – Authors' reply
|
Payne, Amanda B |
|
|
406 |
10503 |
p. 599-600 |
artikel |
19 |
Revisiting primary hyperparathyroidism guidelines
|
Menon, Sonia |
|
|
406 |
10503 |
p. 597-598 |
artikel |
20 |
Revisiting the role of α1-antitrypsin deficiency in aortic aneurysms and dissections
|
Yang, Chengliang |
|
|
406 |
10503 |
p. 599 |
artikel |
21 |
The art of the emergency
|
Bahra, Jasdeep |
|
|
406 |
10503 |
p. 592-593 |
artikel |
22 |
The famines in Gaza and other conflict areas are a moral failure
|
Osendarp, Saskia |
|
|
406 |
10503 |
p. 572-573 |
artikel |
23 |
The Partnership for Maternal, Newborn, and Child Health: 2026–30 strategy
|
Clark, Helen |
|
|
406 |
10503 |
p. 596-597 |
artikel |
24 |
Timing of cardiac surgery and anticoagulants after acute ischaemic stroke
|
Pocar, Marco |
|
|
406 |
10503 |
p. 600-601 |
artikel |
25 |
Timing of cardiac surgery and anticoagulants after acute ischaemic stroke
|
Cheng, Szu-Ping |
|
|
406 |
10503 |
p. 601 |
artikel |
26 |
Timing of cardiac surgery and anticoagulants after acute ischaemic stroke – Authors' reply
|
Werring, David J |
|
|
406 |
10503 |
p. 601-602 |
artikel |
27 |
Tumani Corrah: cultivating health research capacity in Africa
|
Prasad, Aarathi |
|
|
406 |
10503 |
p. 589 |
artikel |
28 |
Vesicular monoamine transport inhibitors: current uses and future directions
|
Rosenthal, Liana S |
|
|
406 |
10503 |
p. 650-664 |
artikel |